BSEAGM/EGM1d ago · 3 Aug 2026, 07:44 pm
Voting Result and Scrutinizer report for EGM held on 31st July, 2026 through VC-OAVM
Asston Pharmaceuticals Ltd · 544445
✦ AI Summary
Asston Pharmaceuticals Ltd has announced the voting results and scrutinizer's report for its Extraordinary General Meeting (EGM) held on July 31, 2026, through video conferencing. The meeting was attended by 3 promoters and 0 public shareholders, and 1 resolution was passed, which was to issue equity shares on a preferential basis.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Asston Pharmaceuticals Ltd - 544445 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Attachments (1)
📄pdf
Download →
4cd3147f-da1d-47d7-b35b-c5fc26ba1ee5.pdf
View document text
ASSTON PHARMACEUTICALS LIMITED
(FORMERLY KNOWN AS ASSTON PHARMACEUTICALS PRIVATE LIMITED)
To, Date: 03/08/2026
BSE Limited (BSE Ltd)
Listing / Compliance Department,
Dalal Street, Mumbai— 400001
BSE Scrip Code: 544445
Subject: Submission of Scrutinizer's Report along with the Voting Results of the Extraordinary
General Meeting of Asston Pharmaceuticals Limited held on 31* July, 2026.
Ref: Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Dear Sir/Madam,
This is to inform you that the Extraordinary General Meeting of the Members of Asston
Pharmaceuticals Limited was held on Friday, 31% July, 2026 at 12.30 P.M. through Video Conferencing.
Pragya Jain, Proprietor of M/s Pragya & Associates (Mem. No. 65240), Practicing Company Secretaries,
Indore, was appointed as the Scrutinizer to oversee the E-voting process.
In this regard, please find enclosed the following:
1. Voting results of the businesses transacted at the EGM, as required under Regulation 44(3) of the
Listing Regulations.
2. Report of the Scrutinizer dated 03.08.2026, pursuant to Sections of the Companies Act, 2013 and
Rule 20 of the Companies (Managemeanntd Administration) Rules, 2014.
The EGM concluded at 12:51 P.M.
You are requested to please take note of the same.
For Asston Pharmaceuticals Limited
Rishi Upadhaya
Company Secretary and Compliance Officer
A74234
Place: Mumbai
Encl: Attached
CIN: U24304MH2019PLC324187
Reg. Office- 4th Floor Office No A-431 Balaji Bhavan, Plot No 42a Sector-11 CBD Belapur, Navi
Mumbai, Thane, Maharashtra, 400614, India
Phone No.: 022-49731419 / 49731411, Email id:
aston.tech14@gmail.com/compliance @asstonpharmaceuticals.com
Web: www.asstonpharmaceuticals.com
ASSTON PHARMACEUTICALS LIMITED
(FORMERLY KNOWN AS ASSTON PHARMACEUTICALS PRIVATE LIMITED)
Voting results
Record date 24-07-2026
Total number of shareholders on record date 77
No. of sharcholders present in the meeting cither in person or through proxy
) Promoters and Promoter group o
b) Public 0
No. of sharcholders attended the meeting through video conferencing
) Promoters and Promoter group 3
b) Public :
No. of resolution passed in the meeting 1
Disclosure of notes on voting results
CIN: U24304MH2019PLC324187
Reg. Office- 4th Floor Office No A-431 Balaji Bhavan, Plot No 42a Sector-11 CBD Belapur, Navi
Mumbai, Thane, Maharashtra, 400614, India
Phone No.: 022-49731419 / 49731411, Email id:
aston.tech14@gmail.com/compliance @asstonpharmaceuticals.com
Web: www.asstonpharmaceuticals.com
ASSTON PHARMACEUTICALS LIMITED
(FORMERLY KNOWN AS ASSTON PHARMACEUTICALS PRIVATE LIMITED)
Resolution(1)
Resolution required: (Ordinary / Special) Special
‘Whether promoter/promoter group are interested in the
agenda/resolution? No
Description of resolution considered TO ISSUE EQUITY SHARES ON PREFERENTIAL BASIS.
Mode of No.of | % of Votes p(?lkd No. of No. of % of votes in n/," of Votes
Category votes | onoutstanding | voies—in | votes— | favour on votes | againston votes
Vel polled shares favour | against polled polled
E-Voting 4312480 | 100 4312480 0 100 0
Bl B 4312480 |° 0 0 0 0 0
romoter
Giowp :fi:;fi::::» 0 0 0 0 0 0
Toul 4312450 4312480 [100 Bnas0 o 100 0
E-Voting 0 0 0 0 0 0
Pablic: Poll o 0 0 o 0 0 0
Institutions 5‘?‘.‘:,',.‘?3!311. 0 0 0 0 0 0
Toul 0 0 0 0 0 0 0
E-Voting 370104 88123 70106 |0 100 0
® | if applicable) o N % o s o
Toul 4199880 [370104 88123 370104 |0 100 0
Total 8512360 | 4682584 |55.0092 4682584 0 100 0
Whether resolution is Pass or Not. | Yes
Disclosure of notes on resolution
Details of Invalid Votes
Category No. of Votes
Promoter and Promoter Group 0
Public Insitutions 0
Public - Non Insitutions 0
CIN: U24304MH2019PLC324187
Reg. Office- 4th Floor Office No A-431 Balaji Bhavan, Plot No 42a Sector-11 CBD Belapur, Navi
Mumbai, Thane, Maharashtra, 400614, India
Phone No.: 022-49731419 / 49731411, Email id:
aston.tech14@gmail.com/compliance @asstonpharmaceuticals.com
Web: www.asstonpharmaceuticals.com
PRAGYA & ASSOCIATES
Practicing Company Secretaries & Trademark Agent
SCRUTINIZER'S REPORT
(Pursuant to Section 108 of the Companies Act, 2013 and Rule 20 of the Companies,
{Management and Administration) Rules, 2014 as amended)
The Chairman
Asston Pharmaceuticals limited
4th Fioor Office No A-431 Balaji Bhavan,
Plot No 42a Sector-11 CBD, Belapur,
Navi Mumbai, Thane, Maharashtra, india, 400614
Scrutinizer’s Report on remote e-voting/poll at the Extra-Ordinary General Meeting of Asston Pharmaceuticals
Limited held on Friday, the 31 July, 2026 at 12:30 P.M. through video/audio means
Dear Sir,
I, Pragya Jain, Company Secretary in Practice, have been appointed as Scrutinizer by the Board of Directors of
Asston Pharmaceuticals Limited (“the Company”) for the purpose of scrutinizing the process of voting through
electronic means ("e-voting") in a fair and transparent manner on the resolutions contained in the notice
dated 02" July, 2026 ("Notice") pursuant to the provisions of Section 108 of the Companies Act, 2013, read
with Rule 20 of the Companies (Management and Administration) Rules, 2014 and MCA circulars as amended
from time to time.
Management's Responsibility
The management of the Company is responsible to ensure compliance with the requirements of (i) the Act and
the Rules made thereunder; (ji) the MCA Circulars; and (iii) the Securities and Exchange Board of India (Listing
Obligations and Disciosure Requirements) Regulations, 2015 relating to e-voting on the resolutions contained
in the Notice. The management of the Company is responsible for ensuring a secured framework and
robustness of the electronic voting systems.
Scrutinizer's Responsinility
My responsibility as a Scrutinizer for e-voting process is restricted to making a Scrutinizer's Report of the votes
cast “in favour” or "against" the resolutions contained in the Notice, based on the reports generated from the
e-voting system provided by N5DL, being an agency authorized under the Act and the Rules made thereunder
engaged by the Company to provide e-voting facility, and attendant papers / documents furnished to me
electronically by the Company and/ or NSDL for my verification.
E-Voting process
In accordance with the Notice of the Extra Ordinary General Meeting sent to the shareholders, the
remote e-voting period begins on Tuesday, 28th July, 2026, at 09:00 A.M. and ends on Thursday, 30th
July, 2026, at 05:00 P.M.
The equity shareholders as on Friday, 24th July, 2026, (cut-off date) were entitled to vote on the
resolutions as st aut in the notice of the Extra Ordinary General Meeting of the Company.
After the time fixed for closing of the e-voting i.e. 5.00 PM on 30™ July, 2026 and e-voting process (15
minutes) after the EGM on 31* July, 2026, a final electronic report of the e-voting was generated by me
by accessing the data available to me from the website of NSDL i.e. https://www.evoting.nsdl.com.
Monpile No.: +91 9630093827 Email id: info@ pragyaandassociates.com
174 A Mansarovar nagar, Indore, Madhya Pradesh, 452010, India
PRAGYA & ASSOCIATES
Practicing Company Secretaries & Trademark Agent
| submit herewith the Scrutinizer's Report on the results of the e-voting, based on the reports generated by
NSDL, scrutinized or test check basis and relied upon by me as under:
Item No. of the Notice Votes in favour of the | Votes against the | Number of
resolution resolution invalid votes
Number of | % of Total | Number | % of Total
valid votes | Number of | of valid | Number of
Valid Votes | votes Valid Votes
Item No. 1: 4682584 100 o o o
TO ISSUE EQUITY SHARES ON
PREFERENTIAL BASIS
(As a Special Resolution) |
The electronic data and all other relevant records relating to e-voting will be handed over to Company
Secretary and Compliance Officer of the Company for safe keeping as provided in the Act read with the
relevant Rules.
Restriction on Use E
This report has been issued at the request of the Company for (i) submission to Stock Exchanges, (ii) placing on
website of the Company, (iii) placing on th
[Showing first 8,000 characters — download PDF for full document]